Artemis Therapeutics, Inc. (ATMS)
Stock Price: $2.41 USD
0.04 (1.65%)
Updated Jun 11, 2021 1:34 PM EDT - Market closed
| Market Cap | 11.54M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -136,000 |
| Shares Out | 5.15M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 11 |
| Last Price | $2.41 |
| Previous Close | $2.37 |
| Change ($) | 0.04 |
| Change (%) | 1.65% |
| Day's Open | 2.41 |
| Day's Range | 2.41 - 2.41 |
| Day's Volume | 1,046 |
| 52-Week Range | 0.04 - 3.75 |
News
There are no news available yet.
About ATMS
Artemis Therapeutics Inc. does not have significant operations. Previously, it was engaged in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc. is a subsidiary of Tonak Ltd.
| Industry Biotechnology | |
| Stock Exchange OTCMKTS | Ticker Symbol ATMS |
Analyst Forecasts
The average 12-month stock price forecast for ATMS is 3.50, which is an increase of 45.29% from the latest price.
Price Target
$3.50
(45.29% upside)